Contego Medical LLC announced recently that it has received CE Marking of its Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection (IEP). The company intends to launch the Vanguard IEP System in Europe to endovascular specialists performing lower limb angioplasty procedures.
An analysis of non ST-elevation myocardial infarction (NSTEMI) patients who undergo coronary revascularization within 24 hours of hospitalization showed an increased reduction in mortality, marking the first time this difference has been demonstrated. Results from “Outcomes of Early vs. Late Revascularization in Low and High-Risk Patients Hospitalized with Non-ST-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Surveillance Study” were presented as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions, May 10-13 in New Orleans.
May 16, 2017 - The preliminary results for the Medtronic Micra Transcatheter Pacing System (TPS) Post-Approval Registry ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 16, 2017 - The study using small, subcutaneous implantable cardiac monitors for long-term, 24-hour a day monitoring ...
May 16, 2017 – A new study examines the effectiveness of the implantable subcutaneous string defibrillator (ISSD), a ...
The largest real-world study of robotic percutaneous coronary intervention (PCI) demonstrated clinical and technical success for patients across multiple sites using multiple operators. Results from the PRECISION trial (Efficacy and Safety Outcomes of Radial- vs Femoral-Access Robotic Percutaneous Coronary Intervention: Final Results of the Multicenter PRECISION Registry) were presented as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions, May 10-13 in New Orleans.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Adept Medical announced the launch of the IR Platform, designed as an over-patient work surface for vascular and interventional radiology. The platform provides clinical benefits to the current practice of laying procedural equipment over the patient’s legs by offering a stable, radiolucent, height- and length-appropriate solution for femoral artery access procedures. It offers a stable solution for catheter/guide wire manipulation, with a large work area for equipment.
May 16, 2017 — Here is a list of the late-breaking clinical trials presented at the Heart Rhythm Society (HRS) 2017 ...
May 16, 2017 – Results of a groundbreaking clinical trial demonstrate the effectiveness of a novel, fast-acting nasal ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
This video, provided by Medtronic, demonstrates the implantation of Micra transcatheter pacing system (TPS). The device ...
Soundwaves LLC recently announced the diversification of its portable ultrasound services beyond obstetrics and gynecology to other medical disciplines, including cardiology, and the expansion of its operations from South Florida to the Mid-Atlantic.
May 15, 2017 – The Heart Rhythm Society (HRS) in joint partnership with several other electrophysiology societies issued ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
A first-of-its-kind study discovered that women and minorities who underwent a percutaneous coronary intervention (PCI) are at greater risk of experiencing recurrent cardiac events within the first year after their procedure compared to Caucasian men. Those outcomes may be attributable to their race, gender and socioeconomic status rather than the PCI procedure itself. Results from “Interaction Effects of Race/Ethnicity and Sex on Outcomes after PCI: A Subanalysis of the PLATINUM Diversity study” were presented as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions May 10-13 in New Orleans.
May 15, 2017 — The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement in the United States on ...
For patients who undergo transcatheter aortic valve replacement (TAVR), their risk factors, not the type of valve used, determined their 30-day post-TAVR outcomes. Results from “Impact of valve design and bivalirudin vs. unfractionated heparin for anticoagulation in transcatheter aortic valve replacement: Results from the BRAVO-3 trial” were presented as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions, May 10-13 in New Orleans.